Connection

Syed Hasan to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Syed Hasan has written about Randomized Controlled Trials as Topic.
Syed Hasan
Connection Strength
0.503
Randomized Controlled Trials as Topic
  1. Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials? Int J Infect Dis. 2020 Dec; 101:107-120.
    View in: PubMed
    Score: 0.219
  2. The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review. Expert Rev Anti Infect Ther. 2022 02; 20(2):211-229.
    View in: PubMed
    Score: 0.058
  3. Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Hypertens Res. 2021 08; 44(8):1042-1045.
    View in: PubMed
    Score: 0.057
  4. The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep. 2021 Oct; 73(5):1473-1479.
    View in: PubMed
    Score: 0.057
  5. The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2021 Aug; 77(8):1089-1094.
    View in: PubMed
    Score: 0.056
  6. Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials. J Med Virol. 2021 04; 93(4):1860-1861.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.